Premier Dental
Fitness Beverage

Space Calcium Intake From Certain Prescriptions

Bioavailable calcium can reduce the absorption of several commonly prescribed medications via cation chelation. Consumers taking levothyroxine (thyroid hormone), bisphosphonates (osteoporosis therapy), tetracycline-class antibiotics, or fluoroquinolone antibiotics should separate consumption of calcium-containing beverages and supplements from these medications by at least two hours. This is a standard pharmacy-level recommendation and applies to any calcium-containing food or beverage, not uniquely to AquaBite. Consult your pharmacist or prescriber for medication-specific timing.

Transparency on Emerging Research

Erythritol is a naturally occurring sugar alcohol that holds FDA Generally Recognized As Safe (GRAS) status and is present in many fruits and fermented foods as well as in food-use products. AquaBite Choice™ uses erythritol at sub-sensory dosing (~300–400 mg/L), a small fraction of amounts typically associated with any documented effect.

A 2023 observational study (Witkowski et al., Nature Medicine; PMID 36849732) reported an association between elevated circulating erythritol and cardiovascular events in at-risk populations. Subsequent methodological commentary has emphasized that endogenous (internally produced) erythritol likely drove much of the observed signal, and that FDA GRAS status for dietary erythritol at food-use levels remains in effect. Consumers with established cardiovascular disease should discuss overall dietary polyol intake with their physician.

Why Choice Exists

AquaBite Choice™ is fluoride-free by design. This formulation may be preferred by consumers who already receive fluoride from prescription dentifrice, professional fluoride varnish, or community water sources; consumers with chronic kidney disease (in whom reduced fluoride clearance can lead to skeletal accumulation); and consumers who have selected a fluoride-free lifestyle. Choice is not a fluoride substitute and is not a dental caries preventive; it is a hydration option designed to support mucosal hydration, oral-microbiome balance, and enamel mineral density in its target consumer. Your dentist is the appropriate clinician to determine your individual fluoride needs.

Scope of Benefit Without Natural Dentition

Enamel-centric benefits apply to consumers with natural dentition. Adults who wear complete or partial dentures may still benefit from Choice's support of mucosal hydration (betaine as a food-grade osmoprotectant) and neutral-pH, zero-sugar hydration that does not aggravate mucosal tissue. Choice does not treat denture stomatitis, denture-related candidiasis, or any oral mucosal disease. Denture-wearing consumers experiencing persistent dry mouth, mucosal discomfort, or prosthesis-related concerns should consult their dentist.

A Note for Consumers on Multiple Medications

Over 500 prescription and non-prescription medications can contribute to xerostomia, commonly observed in consumers taking multiple medications concurrently (Sreebny & Schwartz, Gerodontology, 1997; Villa et al., Aging Clinical and Experimental Research, 2015). Betaine — a food-grade osmoprotectant in AquaBite Choice™ — has been associated with relief of subjective dry-mouth symptoms in randomized clinical trials using topical oral vehicles (Rantanen et al., J Contemp Dent Pract, 2003; PMID 12761586). A separate double-blind study of a topical oral product containing betaine reported safety and effectiveness in polypharmacy-induced xerostomia (Ship et al., J Oral Rehabil, 2007; PMID 17824884). These studies used topical vehicles, not beverages; AquaBite Choice™ delivers betaine in a food-grade beverage and supports mucosal hydration. Choice does not treat xerostomia or any underlying condition. Persistent dry mouth warrants evaluation by your physician, pharmacist, or dentist.